Arrowhead Pharmaceuticals Inc Sustainability Reports

Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them through RNA interference mechanisms.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 549300O3CSB8T7OZ3D66

FIGI: BBG001SGT8G5

7 reports from 2007 to 2024

• Arrowhead Pharmaceuticals Inc 2024 Annual Report
• Arrowhead Pharmaceuticals Inc 2023 Annual Report
• Arrowhead Pharmaceuticals Inc 2021 Form 10-K
• Arrowhead Pharmaceuticals Inc 2016 Form 10-K
• Arrowhead Pharmaceuticals Inc 2015 Annual Report